title: Prevention of Pneumocystis carinii pneumonia relapse by aerosolised pentamidine, 60 mg biweekly, using an Acorn System 22 nebuliser.
abstract: The effectiveness of biweekly administration of 60 mg aerosolised pentamidine (AP) as secondary prophylaxis against relapse of Pneumocystis carinii pneumonia (PCP) was investigated in 45 male AIDS patients. The nebuliser used was an Acorn System 22. In total the patients received AP for a mean period of 13.8 months (3.4-28.8). Six episodes of recurrent PCP were recorded. Relapse per full year of treatment on AP was 12%.
authors: Department of Infectious Diseases, State University Hospital, Copenhagen, Denmark.
authors: B N
authors: BN
authors: Jensen
authors: T L
authors: TL
authors: Nielsen
authors: B
authors: B
authors: Lerche
authors: T H
authors: TH
authors: Jensen
authors: V
authors: V
authors: Backer
authors: L
authors: L
authors: Mathiesen
authors: J O
authors: JO
authors: Nielsen
authors: P
authors: P
authors: Skinhøj
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000328:Adult; D000336:Aerosols; D006801:Humans; D008297:Male; D008875:Middle Aged; D009330:Nebulizers and Vaporizers; D010349:Patient Compliance; D010419:Pentamidine / Q000008:administration & dosage / Q000627:therapeutic use*; D011020:Pneumonia, Pneumocystis / Q000150:complications / Q000517:prevention & control*; D012008:Recurrence
chemical_list: D000336:Aerosols; D010419:Pentamidine